A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa
Public ClinicalTrials.gov record NCT04988308. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a/2b, Multicenter, Randomized, Placebo and Active Comparator-controlled, Double-Blind, Dose-ranging Study to Evaluate the Safety and Efficacy of Bermekimab (JNJ-77474462) for the Treatment of Subjects With Moderate to Severe Hidradenitis Suppurativa
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the clinical efficacy of bermekimab in participants with moderate to severe Hidradenitis Suppurativa (HS).
Study identification
- NCT ID
- NCT04988308
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 151 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 12, 2021 (Actual)
- Primary completion
- Oct 14, 2022 (Actual)
- Completion
- Nov 23, 2022 (Actual)
- Last update posted
- Nov 13, 2023
2021 – 2022
United States locations
- U.S. sites
- 22
- U.S. states
- 13
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medical Dermatology Specialists | Phoenix | Arizona | 85006 | — |
| First OC Dermatology | Fountain Valley | California | 92708 | — |
| Center for Dermatology Clinical Research | Fremont | California | 94538 | — |
| Wallace Medical Group, Inc. | Los Angeles | California | 90056 | — |
| Renstar Medical Research | Ocala | Florida | 34470 | — |
| Forcare Clinical Research, Inc. | Tampa | Florida | 33613 | — |
| Dawes Fretzin Clinical Research Group | Indianapolis | Indiana | 46256 | — |
| Indiana Clinical Trial Center | Plainfield | Indiana | 46168 | — |
| Allcutis Research | Beverly | Massachusetts | 01915 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Clarkston Dermatology & Vein Center, PLLC | Clarkston | Michigan | 48346 | — |
| Somerset Skin Centre | Troy | Michigan | 48084 | — |
| Minnesota Clinical Study Center | New Brighton | Minnesota | 55112 | — |
| JDR Dermatology Research | Las Vegas | Nevada | 89148 | — |
| ActivMed Practices & Research | Portsmouth | New Hampshire | 03801 | — |
| Wright State Physicians Health Center | Dayton | Ohio | 45324 | — |
| Penn State Milton S. Hershey Medical Ctr. | Hershey | Pennsylvania | 17033 | — |
| Clinical Partners | Johnston | Rhode Island | 02919 | — |
| Arlington Center for Dermatology | Arlington | Texas | 76011 | — |
| Modern Research Associates | Dallas | Texas | 75231 | — |
| Center for Clinical Studies | Houston | Texas | 77004 | — |
| Progressive Clinical Research | San Antonio | Texas | 78213 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04988308, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 13, 2023 · Synced Nov 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04988308 live on ClinicalTrials.gov.